Loading...
XSHG600079
Market cap5.29bUSD
Dec 26, Last price  
23.63CNY
1D
-0.42%
1Q
22.06%
Jan 2017
18.45%
Name

Humanwell Healthcare Group Co Ltd

Chart & Performance

D1W1MN
XSHG:600079 chart
P/E
18.07
P/S
1.57
EPS
1.31
Div Yield, %
1.52%
Shrs. gr., 5y
4.58%
Rev. gr., 5y
5.34%
Revenues
24.52b
+9.79%
592,307,749747,904,699750,644,229709,220,3351,024,369,4641,330,209,2172,204,798,7993,621,436,0515,317,093,0096,010,211,3977,051,628,03710,053,978,40312,330,950,05215,448,209,51918,910,551,30322,157,422,64420,680,111,11420,548,930,20322,337,719,41724,524,740,572
Net income
2.13b
-14.07%
40,218,85751,433,700107,474,28769,440,55778,197,554201,472,882216,466,205300,354,201405,990,787417,780,076451,770,962653,823,533832,403,3882,068,592,97401,315,211,0211,642,188,8751,818,192,7982,484,108,5852,134,484,688
CFO
1.97b
-19.41%
70,552,825127,130,68284,437,97455,050,30934,969,189154,510,417111,386,11894,231,577172,273,069498,216,711502,704,784311,216,560526,477,79038,167,500602,993,6212,037,831,5531,988,506,2722,178,810,5202,441,071,0541,967,249,725
Dividend
Oct 11, 20240.15 CNY/sh

Profile

Humanwell Healthcare (Group) Co.,Ltd. provides healthcare solutions in the Asia Pacific, North America, Africa, and internationally. The company offers anesthetic/analgesic products; women's health products for unplanned pregnancy, emergency contraception, and birth control; consumer healthcare products for women; and CNS drugs for bronchitis, migraine, dysmenorrhea, neuralgia, epilepsy, acute and chronic cerebrovascular diseases, and brain injury and peripheral vascular diseases. It also provides herbal medicines for cold and flu, rheumatoid arthritis, skin care, hepatitis, urinary tract infection, and hypomnesis; anti-infection drugs; OTC medicines for digestive disorders, cold and flu, anti-inflammation, anti-infection, and nutritional supplements; and other products targeting cardiovascular, gastrointestinal, and reproductive diseases. The company was formerly known as Wuhan Humanwell Healthcare (Group) Co., Ltd. and changed its name to Humanwell Healthcare (Group) Co.,Ltd. in March 2013. Humanwell Healthcare (Group) Co.,Ltd. was founded in 1993 and is based in Wuhan, China.
URL
http://www.humanwell.com.cn
IPO date
Jun 06, 1997
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
24,524,741
9.79%
22,337,719
8.71%
20,548,930
-0.63%
Cost of revenue
18,695,693
18,270,729
16,581,985
Unusual Expense (Income)
NOPBT
5,829,048
4,066,990
3,966,945
NOPBT Margin
23.77%
18.21%
19.30%
Operating Taxes
568,563
354,751
354,782
Tax Rate
9.75%
8.72%
8.94%
NOPAT
5,260,485
3,712,240
3,612,163
Net income
2,134,485
-14.07%
2,484,109
36.63%
1,818,193
10.72%
Dividends
(587,689)
(244,723)
(160,953)
Dividend yield
1.45%
0.64%
0.44%
Proceeds from repurchase of equity
(3,891)
BB yield
0.01%
Debt
Debt current
7,520,816
8,344,225
9,629,354
Long-term debt
1,823,736
1,953,414
3,398,293
Deferred revenue
601,128
570,161
Other long-term liabilities
797,108
21,380
44,274
Net debt
2,267,439
2,428,072
2,506,290
Cash flow
Cash from operating activities
1,967,250
2,441,071
2,178,811
CAPEX
(1,958,320)
Cash from investing activities
1,226,790
Cash from financing activities
(2,113,807)
FCF
120,096
2,114,768
2,432,603
Balance
Cash
5,040,838
6,121,949
6,100,022
Long term investments
2,036,276
1,747,618
4,421,335
Excess cash
5,850,877
6,752,681
9,493,910
Stockholders' equity
14,044,625
12,534,811
10,218,733
Invested Capital
24,270,722
21,765,946
19,183,409
ROIC
22.85%
18.13%
19.26%
ROCE
19.11%
14.06%
13.71%
EV
Common stock shares outstanding
1,629,378
1,613,058
1,615,750
Price
24.83
3.93%
23.89
6.08%
22.52
-33.53%
Market cap
40,457,446
4.99%
38,535,944
5.91%
36,386,688
-22.39%
EV
45,779,897
43,869,306
41,596,517
EBITDA
6,654,464
4,815,042
4,646,284
EV/EBITDA
6.88
9.11
8.95
Interest
409,251
476,568
1,159,010
Interest/NOPBT
7.02%
11.72%
29.22%